13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

9 trials found

diseases per page:

Showing 1 to 9 of 9 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-005493-11-FR (EUCTR)	31/08/2015	15/03/2018	Study the action of a single dose of intrathecally-infused rituximab upon cerebro-spinal fluid (CSF) ...	Intrathecal Rituximab in Progressive Multiple Sclerosis - EFFRITE	Patients included in our study suffer from a progressive form of Multiple sclerosis and will be trea ...	Trade Name: Méthylprednisolone Mylan Product Name: méthylprednisolone Trade Name: Mabthera Product Name: ...	Centre Hospitalier de Pau	NULL	Not Recruiting			Female: yes Male: yes	12	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	France
2	NCT02398994 (ClinicalTrials.gov)	March 2015	23/3/2015	A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for ...	A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin (IVIg) Versus Standard Thera ...	Myelitis, Transverse;Neuromyelitis Optica	Drug: Intravenous Methylprednisolone;Drug: Intravenous Immunoglobulin	Guy's and St Thomas' NHS Foundation Trust	King's College London;Barts and the London School of Medicine and Dentistry;Cardiff University;Unive ...	Terminated	1 Year	N/A	Both	2	Phase 3	United Kingdom
3	NCT01900093 (ClinicalTrials.gov)	July 2013	11/7/2013	Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolo ...	An Open-Label Prospective Proof-Of-Concept Trial to Evaluate the Response to Acthar Gel Therapy in P ...	Multiple Sclerosis	Drug: Acthar Gel	Aaron Miller	Mallinckrodt	Recruiting	18 Years	65 Years	All	10	N/A	United States
4	EUCTR2009-013884-21-PL (EUCTR)	20/05/2010	13/01/2010	A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG ...	A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG ...	Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Sy ...	Product Name: PEG -liposomal Prednisolone Sodium Phosphate Product Code: Nanocort INN or Proposed INN: ...	Enceladus Pharmaceuticals BV	NULL	Not Recruiting			Female: yes Male: yes	90		Germany;Belgium;Poland
5	NCT01039103 (ClinicalTrials.gov)	December 2009	20/12/2009	Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)	A Randomized, International, Multi Centre Study to Assess the Efficacy and Safety of Intravenous PEG ...	Acute Exacerbation of Remitting Relapsing Multiple Sclerosis;Clinically Isolated Syndrome	Drug: PEG -liposomal prednisolone sodium phosphate;Drug: Methylprednisolone	Galapagos NV	NULL	Terminated	18 Years	65 Years	Both	15	Phase 2	Belgium;Germany;Poland
6	EUCTR2009-013884-21-DE (EUCTR)	18/11/2009	09/09/2009	A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG ...	A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG ...	Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Sy ...	Product Name: PEG -liposomal Prednisolone Sodium Phosphate Product Code: Nanocort INN or Proposed INN: ...	Enceladus Pharmaceuticals BV	NULL	Not Recruiting			Female: yes Male: yes	90		Poland;Belgium;Germany
7	EUCTR2009-013884-21-BE (EUCTR)	13/11/2009	10/09/2009	A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG ...	A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG ...	Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Sy ...	Product Name: PEG -liposomal Prednisolone Sodium Phosphate Product Code: Nanocort INN or Proposed INN: ...	Enceladus Pharmaceuticals BV	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 2	Poland;Belgium;Germany
8	NCT00947895 (ClinicalTrials.gov)	October 2009	2/7/2009	Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-re ...	Relative Efficacy of Repeat Course of Intravenous methyLprednisoloneand Intramuscular ACTH in the Tr ...	Multiple Sclerosis	Drug: Methylprednisolone;Drug: ACTH;Other: IV placebo;Other: IM placebo	Neurologique Foundation, Inc.	Mallinckrodt	Terminated	18 Years	N/A	Both	30	Phase 2/Phase 3	United States
9	NCT00112034 (ClinicalTrials.gov)	June 2003	27/5/2005	AVONEX® Combination Trial - ACT	A Multi-Center, Randomized, Blinded, Parallel-Group Study of AVONEX Compared With AVONEX in Combinat ...	Multiple Sclerosis, Relapsing-Remitting	Drug: Methotrexate;Drug: IV methylprednisolone	Biogen Idec	NULL	Completed	18 Years	55 Years	Both	350	Phase 4	United States

First Previous1Next Last